Pharmaceutical Logistics Market Size, Growth Analysis & Future Outlook 2026-2033 | North America Leads Global Market with 38.9% Share | Top Players Deutsche Post AG, FedEx Corporation, CEVA Logistics SA

The global pharmaceutical logistics market reached USD 84.18 billion in 2025 and is projected to reach USD 162.42 billion by 2033, expanding at a CAGR of 7.8% during the forecast period from 2026 to 2033. The market has become a critical investment segment within the global healthcare supply chain, driven by the rising demand for temperature-controlled transportation, increasing production of biologics and specialty pharmaceuticals, expanding global vaccine distribution, and stringent regulatory requirements for drug safety and traceability. Investors are increasingly focusing on companies specializing in cold chain logistics, warehousing, last-mile delivery, and digital supply chain solutions that ensure the secure and timely movement of high-value pharmaceutical products. Growing investments in refrigerated transportation infrastructure, automated distribution centers, and real-time monitoring technologies are strengthening the industry's long-term growth outlook.

Investment momentum continues to accelerate as logistics providers, pharmaceutical manufacturers, and technology companies expand cold chain networks and adopt advanced digital logistics solutions. Strategic partnerships, capacity expansions, and innovations in IoT-enabled tracking, AI-powered route optimization, blockchain-based traceability, and automated warehouse management are enhancing supply chain visibility and operational efficiency. The increasing demand for biologics, personalized medicines, cell and gene therapies, and global clinical trial logistics is creating new commercial opportunities across both developed and emerging markets. As governments strengthen healthcare infrastructure and pharmaceutical companies prioritize resilient and compliant supply chains, the pharmaceutical logistics market is expected to remain a high-priority investment sector, supporting the efficient global distribution of life-saving medicines and next-generation healthcare products.

Get a Free Sample PDF of This Report (Get Higher Priority for Corporate Email ID):https://www.datamintelligence.com/download-sample/pharmaceutical-logistics-Market?sai-v

Key Developments

July 2026: DHL Group (Europe) expanded its global GDP-compliant cold chain logistics network by opening new temperature-controlled distribution facilities, strengthening the transportation of vaccines, biologics, and specialty pharmaceuticals.

June 2026: FedEx (North America) launched advanced real-time shipment monitoring solutions integrating AI-driven predictive analytics and IoT-enabled sensors to improve visibility and temperature control for pharmaceutical deliveries.

May 2026: Kuehne+Nagel (Europe) expanded its healthcare logistics operations by adding new pharmaceutical distribution hubs and validated cold storage infrastructure to support the growing demand for biologics and personalized medicines.

April 2026: UPS Healthcare (North America) introduced enhanced end-to-end cold chain transportation services for cell and gene therapies, providing ultra-low-temperature logistics and real-time shipment tracking for high-value pharmaceutical products.

February 2026: DSV (Europe) strengthened its pharmaceutical logistics capabilities by expanding GDP-certified warehousing and temperature-controlled transportation services, improving the secure handling of specialty drugs across international markets.

Recent Mergers & Acquisitions
July 2026: UPS Healthcare (North America) acquired a specialty cold chain logistics provider, expanding its capabilities in transporting biologics, cell therapies, and temperature-sensitive pharmaceutical products.

June 2026: DHL Group (Europe) acquired a regional healthcare logistics company to strengthen its pharmaceutical warehousing and last-mile distribution network across emerging markets.

May 2026: Cencora (North America) acquired a specialty pharmaceutical distribution business, enhancing its healthcare logistics network and expanding support for specialty drug manufacturers.

April 2026: Kuehne+Nagel (Europe) acquired a pharmaceutical freight forwarding company, strengthening its global healthcare logistics portfolio and expanding GDP-compliant transportation services.

March 2026: CEVA Logistics (Europe) acquired a life sciences logistics provider to enhance its temperature-controlled transportation, clinical trial logistics, and pharmaceutical supply chain solutions.

Key Players
Deutsche Post AG | FedEx Corporation | CEVA Logistics SA | Nippon Express Holdings | Kerry Logistics Network Limited | Others

Key Highlights
Deutsche Post AG - Holds a 19.6% share, driven by its extensive global pharmaceutical cold chain logistics network, GDP-compliant transportation services, temperature-controlled warehousing, and international healthcare supply chain expertise.

FedEx Corporation - Holds a 16.8% share, supported by its time-critical healthcare logistics solutions, global air cargo network, cold chain transportation capabilities, and specialized pharmaceutical shipping services.

CEVA Logistics SA - Holds a 14.5% share, strengthened by its end-to-end pharmaceutical logistics solutions, temperature-controlled distribution, regulatory compliance expertise, and dedicated healthcare logistics infrastructure.

Nippon Express Holdings - Holds a 12.7% share, fueled by its specialized life sciences logistics services, validated cold chain operations, international freight forwarding, and expanding pharmaceutical transportation network across Asia-Pacific.

Kerry Logistics Network Limited - Holds a 10.9% share, driven by its integrated healthcare logistics services, pharmaceutical warehousing, cold chain management, and cross-border distribution capabilities throughout Asia and global markets.

Others - Hold a combined 25.5% share, comprising AIT Worldwide Logistics, Inc., Yusen Logistics, Air Canada Cargo, Continental Carriers Pvt. Ltd., AWL, and other regional pharmaceutical logistics providers offering temperature-controlled transportation, clinical trial logistics, and last-mile healthcare delivery services.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-logistics-Market?sai-v

Market Drivers
Increasing demand for temperature-sensitive pharmaceuticals, biologics, vaccines, and specialty drugs, along with the expansion of global pharmaceutical trade, is driving the growth of the pharmaceutical logistics market.

Growing adoption of cold chain logistics, real-time shipment monitoring, IoT-enabled tracking systems, and advanced warehouse automation is accelerating market expansion.

Continuous advancements in supply chain digitalization, AI-powered logistics management, predictive analytics, and transportation optimization are improving operational efficiency and product safety.

Rising healthcare expenditure, expanding pharmaceutical manufacturing, stringent regulatory requirements, and increasing investments in healthcare infrastructure are supporting long-term market growth.

Market Opportunities
Growing demand for biologics, cell and gene therapies, personalized medicines, and temperature-controlled logistics is creating significant growth opportunities.

Increasing investments in cold chain infrastructure, automated distribution centers, digital supply chain platforms, and last-mile delivery solutions are expanding revenue potential across global markets.

Continuous advancements in AI-powered route optimization, blockchain-enabled supply chain transparency, autonomous logistics, and smart packaging technologies are opening new avenues for innovation.

Strategic collaborations among pharmaceutical companies, logistics providers, cold chain specialists, and technology firms are accelerating supply chain modernization and global market expansion.

Industry Developments
Rapid advancements in cold chain logistics, automated warehousing, IoT-enabled monitoring systems, AI-driven supply chain management, and digital freight solutions are transforming the pharmaceutical logistics industry.

Increasing integration of cloud computing, blockchain technology, real-time tracking, and predictive analytics is improving shipment visibility, regulatory compliance, and operational efficiency.

Strategic partnerships, mergers, acquisitions, distribution network expansions, and regulatory approvals are strengthening global logistics capabilities and competitive positioning.

Continuous investments in R&D, temperature-controlled transportation, sustainable logistics solutions, and advanced pharmaceutical distribution technologies are supporting long-term market expansion.

Regional Insights
North America 38.9% share: Leads the market with a 38.9% share due to advanced cold chain infrastructure, strong pharmaceutical manufacturing, stringent regulatory standards, and the presence of leading logistics providers.

Europe 29.4% share: Growth is supported by a 29.4% market share, driven by expanding biopharmaceutical production, robust healthcare infrastructure, strong GDP-compliant logistics networks, and increasing cross-border pharmaceutical trade.

Asia Pacific 23.1% share: Fastest-growing region with a 23.1% share, driven by expanding pharmaceutical manufacturing, rising healthcare expenditure, increasing cold chain investments, and growing demand across China, India, Japan, and South Korea.

Latin America 4.5% share: Holds a 4.5% share, supported by improving healthcare infrastructure, increasing pharmaceutical imports and exports, expanding cold chain networks, and rising investments in logistics modernization.

Middle East & Africa 4.1% share: Accounts for a 4.1% share, driven by growing healthcare investments, expanding pharmaceutical distribution networks, improving cold chain capabilities, and increasing demand for temperature-controlled logistics services.

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/pharmaceutical-logistics-Market?sai-v

Key Segments
➥ By Service Type

Cold Chain Logistics: Represents the dominant segment, driven by increasing demand for temperature-controlled transportation of vaccines, biologics, specialty drugs, and other temperature-sensitive pharmaceuticals.

Non-Cold Chain Logistics: Represents a significant segment, supported by the large-scale distribution of conventional medicines, generic drugs, and over-the-counter (OTC) pharmaceutical products.

➥ By Mode of Transport

Air: Represents a significant segment, driven by the need for rapid delivery of high-value, time-sensitive, and temperature-sensitive pharmaceutical products.

Water: Represents a growing segment, supported by cost-effective international transportation of bulk pharmaceutical raw materials and finished products.

Road: Represents the dominant segment, fueled by extensive domestic distribution networks, last-mile delivery, and flexible transportation of pharmaceutical products.

Rail: Represents a moderate segment, driven by increasing adoption for long-distance, cost-efficient transportation across major logistics corridors.

➥ By Pharmaceutical Product Type

Pharmaceutical Chemicals: Represents a significant segment, driven by increasing global trade of active pharmaceutical ingredients (APIs) and specialty chemicals.

Bio-Pharmaceuticals: Represents the fastest-growing segment, supported by rising demand for biologics, vaccines, cell and gene therapies, and stringent cold chain requirements.

Pharmaceutical End Products: Represents the dominant segment, fueled by expanding production and global distribution of prescription drugs, generic medicines, and over-the-counter products.

Others: Represents a moderate segment, driven by growing transportation of clinical trial materials, diagnostic products, medical supplies, and healthcare consumables.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.